v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock [Member]
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ 19,036 $ 0 $ 1 $ 0 $ 367,318 $ (542) $ (347,741)
Beginning balance (in shares) at Dec. 31, 2024   0 12,853,823 1,076,257      
Shares issued during the period for vested restricted stock awards, shares     209,486        
Issuance of common stock upon exercise of stock options 3       3    
Issuance of common stock upon exercise of stock options, shares     5,000        
Stock-based compensation 280       280    
Net loss (3,819)           (3,819)
Other comprehensive gain 28         28  
Ending balance at Mar. 31, 2025 15,528 $ 0 $ 1 $ 0 367,601 (514) (351,560)
Ending balance (in shares) at Mar. 31, 2025   0 13,068,309 1,076,257      
Beginning balance at Dec. 31, 2024 19,036 $ 0 $ 1 $ 0 367,318 (542) (347,741)
Beginning balance (in shares) at Dec. 31, 2024   0 12,853,823 1,076,257      
Exercise of warrants 7,927            
Net loss (19,249)            
Ending balance at Jun. 30, 2025 9,042 $ 0 $ 1 $ 0 376,464 (433) (366,990)
Ending balance (in shares) at Jun. 30, 2025   0 14,872,017 1,076,257      
Beginning balance at Mar. 31, 2025 15,528 $ 0 $ 1 $ 0 367,601 (514) (351,560)
Beginning balance (in shares) at Mar. 31, 2025   0 13,068,309 1,076,257      
Shares issued during the period for vested restricted stock awards, shares     53,708        
Issuance of common stock upon exercise of stock options 7,927       7,927    
Issuance of common stock upon exercise of stock options, shares     1,750,000        
Stock-based compensation 936       936    
Net loss (15,430)           (15,430)
Other comprehensive gain 81         81  
Ending balance at Jun. 30, 2025 9,042 $ 0 $ 1 $ 0 376,464 (433) (366,990)
Ending balance (in shares) at Jun. 30, 2025   0 14,872,017 1,076,257      
Beginning balance at Dec. 31, 2025 (42,958) $ 0 $ 2 $ 0 384,648 (290) (427,318)
Beginning balance (in shares) at Dec. 31, 2025   0 15,537,344 1,076,257      
Shares issued during the period for vested restricted stock awards, shares     112,286        
Sale of shares 805       805    
Sale of shares, shares     168,700        
Stock offering costs (31)       (31)    
Stock-based compensation 3,337       3,337    
Net loss 32,599           32,599
Other comprehensive gain 99         99  
Ending balance at Mar. 31, 2026 (6,149) $ 0 $ 2 $ 0 388,759 (191) (394,719)
Ending balance (in shares) at Mar. 31, 2026   0 15,818,330 1,076,257      
Beginning balance at Dec. 31, 2025 (42,958) $ 0 $ 2 $ 0 384,648 (290) (427,318)
Beginning balance (in shares) at Dec. 31, 2025   0 15,537,344 1,076,257      
Exercise of warrants 0            
Net loss 5,475            
Ending balance at Jun. 30, 2026 (30,346) $ 0 $ 2 $ 0 391,567 (72) (421,843)
Ending balance (in shares) at Jun. 30, 2026   0 16,455,751 1,076,257      
Beginning balance at Mar. 31, 2026 (6,149) $ 0 $ 2 $ 0 388,759 (191) (394,719)
Beginning balance (in shares) at Mar. 31, 2026   0 15,818,330 1,076,257      
Shares issued during the period for vested restricted stock awards, shares     455,969        
Sale of shares 667       667    
Sale of shares, shares     181,452        
Stock offering costs (25)       (25)    
Stock-based compensation 2,166       2,166    
Net loss (27,124)           (27,124)
Other comprehensive gain 119         119  
Ending balance at Jun. 30, 2026 $ (30,346) $ 0 $ 2 $ 0 $ 391,567 $ (72) $ (421,843)
Ending balance (in shares) at Jun. 30, 2026   0 16,455,751 1,076,257